Clinical data | |
---|---|
Pronunciation | /ˈraɪtoʊdriːn/ RY-toh-dreen |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Routes of administration | Oral (tablets), parenteral (IV) |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | ~56% |
Metabolism | Hepatic, metabolites are inactive[1] |
Elimination half-life | 1.7–2.6 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.043.512 |
Chemical and physical data | |
Formula | C17H21NO3 |
Molar mass | 287.359 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Ritodrine (trade name Yutopar) is a tocolytic drug used to stop premature labor.[2] This drug has been removed from the US market, according to FDA Orange Book. It was available in oral tablets or as an injection and was typically used as the hydrochloride salt, ritodrine hydrochloride.